Reuters logo
BRIEF-Acadia Pharmaceuticals says its Swiss Unit, Acadia Pharmaceuticals GmbH, enters into master services agreement with Siegfried AG
December 16, 2016 / 10:27 PM / in 10 months

BRIEF-Acadia Pharmaceuticals says its Swiss Unit, Acadia Pharmaceuticals GmbH, enters into master services agreement with Siegfried AG

Dec 16 (Reuters) - Acadia Pharmaceuticals Inc

* Acadia Pharmaceuticals-On Dec 15, co’s Swiss subsidiary, Acadia Pharmaceuticals GmbH, entered into master services agreement with Siegfried AG

* Acadia Pharmaceuticals-Siegfried has agreed to manufacture, supply pimavanserin tartrate,pharmaceutical ingredient of nuplazid for commerical use

* Acadia Pharmaceuticals-Acadia GmbH has agreed to purchase from Siegfried specified percentages of commercial requirements of pimavanserin tartrate for U.S. & Europe

* Acadia Pharmaceuticals-Term of manufacturing agreement extends for five years and will automatically renew for subsequent two-year terms- SEC Filing Source text: [bit.ly/2hXSNOg] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below